Bevacizumab in the treatment of ovarian cancer

R285

KCE Reports 285 (2017)

CONTACT PERSON
Gudrun BRIAT (NL)
Communication Manager for the KCE
+32 (0)2 287 33 48
+32 (0)475 769 766
Published on: 
2017/05/09